iopromide has been researched along with Anemia, Sickle Cell in 1 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zantomio, D | 1 |
| Dowling, RJ | 1 |
| Grigg, A | 1 |
1 other study available for iopromide and Anemia, Sickle Cell
| Article | Year |
|---|---|
Cerebral vaso-occlusive event with low-osmolar intravenous contrast in a patient with sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Carotid Arteries; Cerebrovascular Disorders; Contrast Media; Female; Hum | 2006 |